Agios to Present at the Cowen 39th Annual Health Care Conference on Monday, March 11, 2019
March 04 2019 - 07:00AM
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of
cellular metabolism to treat cancer and rare genetic diseases,
today announced that the company is scheduled to present at the
Cowen 39th Annual Health Care Conference in Boston on Monday, March
11, 2019 at 12:00 p.m. ET.
A live webcast of the presentation can be accessed under "Events
& Presentations" in the Investors section of the company's
website at www.agios.com. A replay of the webcast will be archived
on the Agios website for at least two weeks following the
presentation.
About AgiosAgios is focused on discovering and
developing novel investigational medicines to treat cancer and rare
genetic diseases through scientific leadership in the field of
cellular metabolism. In addition to an active research and
discovery pipeline across both therapeutic areas, Agios has two
approved oncology precision medicines and multiple first-in-class
investigational therapies in clinical and/or preclinical
development. All Agios programs focus on genetically identified
patient populations, leveraging our knowledge of metabolism,
biology and genomics. For more information, please visit the
company's website at www.agios.com.
Investor & Media Contact:Holly Manning,
617-844-6630Associate Director, Investor
RelationsHolly.Manning@agios.com
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Feb 2024 to Mar 2024
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Mar 2023 to Mar 2024